AIG
KROS icon

American International Group’s Keros Therapeutics KROS Stock Holding History

American International Group’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,653
Closed -$838K – 1438
2024
Q1 		$838K Buy
12,653
+1,465
+13% +$86.9K ﹤0.01% 1395
2023
Q4 		$445K Sell
11,188
-45
-0.4% -$1.41K ﹤0.01% 1739
2023
Q3 		$358K Buy
11,233
+399
+4% +$14.9K ﹤0.01% 1797
2023
Q2 		$435K Buy
10,834
+1,547
+17% +$67.8K ﹤0.01% 1728
2023
Q1 		$397K Buy
9,287
+185
+2% +$9.34K ﹤0.01% 1734
2022
Q4 		$437K Buy
9,102
+560
+7% +$26.2K ﹤0.01% 1666
2022
Q3 		$321K Buy
8,542
+684
+9% +$23.7K ﹤0.01% 1856
2022
Q2 		$217K Buy
7,858
+110
+1% +$4.83K ﹤0.01% 2133
2022
Q1 		$421K Sell
7,748
-545
-7% -$28K ﹤0.01% 1817
2021
Q4 		$485K Sell
8,293
-248
-3% -$12.4K ﹤0.01% 1828
2021
Q3 		$338K Sell
8,541
-203
-2% -$7.22K ﹤0.01% 2097
2021
Q2 		$371K Buy
8,744
+1,013
+13% +$54.9K ﹤0.01% 2118
2021
Q1 		$476K Buy
7,731
+150
+2% +$9.5K ﹤0.01% 1870
2020
Q4 		$535K Buy
7,581
+3,416
+82% +$215K ﹤0.01% 1707
2020
Q3 		$161K Sell
4,165
-96
-2% -$3.81K ﹤0.01% 2267
2020
Q2 		$160K Buy
+4,261
New +$131K ﹤0.01% 2256

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

American International Group's KROS Position: Q2 2024 in Review

American International Group sold out of Keros Therapeutics (KROS) in Q2 2024, closing a stake of 12,653 shares — an estimated $838K sold.

American International Group first reported a position in KROS in Q2 2020 and held it in 16 quarters. The position peaked at $838K in Q1 2024. 152 funds tracked by Wall St. Rank hold KROS as of Q2 2024.

  • American International Group reported no remaining Keros Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 12,653 Keros Therapeutics shares in Q2 2024, an estimated $838K.
  • American International Group first reported a position in Keros Therapeutics in Q2 2020 and held it in 16 quarters.
  • American International Group's Keros Therapeutics position peaked at $838K in Q1 2024.
  • 152 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.